Entries by aaron

Why So Many Doctors Especially Residents Suffer From Burnout Syndrome? – Dr Rahul Chawla

What is Burnout Syndrome (BOS)? Burnout Syndrome is a subjective feeling of being emotionally drained, feeling low and unable to keep with the incessant demands at work place. It occurs in individuals without any prior history of psychological or psychiatric disorders. BOS is often triggered by toxic work environment, stress at work place and discrepancy […]

Navigating Vaccines: How They Help And What Challenges They Face? – Dr Meghana Andankar

Introduction Vaccines are like superheroes for our bodies. They protect us from dangerous diseases and have made our lives much healthier. But sometimes, even superheroes face challenges. Let’s explore how vaccines work, what amazing things they’ve done, and the problems that still need to be tackled. How Vaccines Help? Picture vaccines as tiny teachers for […]

Why UCPMP-2024 Needs Teeth: Moving Beyond Voluntary Compliance

Preamble In the landscape of pharmaceutical marketing ethics, the UCPMP (Uniform Code of Pharmaceutical Marketing Practices) has been a cornerstone, albeit with limited efficacy. The inception of UCPMP-2014 as a voluntary framework aimed to instil Good Marketing Practices within the Indian pharmaceutical industry, yet its lack of enforcement mechanisms rendered it toothless against transgressions. Fast […]

Fortis Hospitals faces Rs 89.53 crore Tax Demand

New Delhi: Fortis Healthcare Ltd disclosed on Friday that one of its subsidiaries, Fortis Hospitals Ltd, has received a significant tax demand amounting to Rs 89.53 crore, inclusive of interest, for the assessment year 2022-23.                                           […]

FDA okays pemivibart to prevent COVID-19 in immunocompromised patients

Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for monoclonal antibody pemivibart to prevent COVID-19 in immunocompromised patients. Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company today announced that PEMGARDA™ (pemivibart), formerly VYD222, a half-life extended monoclonal antibody (mAb), has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) […]

Tobacco exposure early in life can increase risk of development of diabetes later: Study

China: A new study shows a strong correlation between tobacco exposure early in life, whether in the womb or during childhood and adolescence and type 2 diabetes (T2D) development later in life. The large-scale observational analysis extracted records of about 476,000 adults in the UK Biobank. Researchers report that people with preexisting genetic factors for […]